Your browser doesn't support javascript.
loading
Simultaneous Determination of Imatinib, Dasatinib, and Nilotinib by Liquid Chromatography-Tandem Mass Spectrometry and Its Application to Therapeutic Drug Monitoring.
Wojnicz, Aneta; Colom-Fernández, Beatriz; Steegmann, Juan L; Muñoz-Calleja, Cecilia; Abad-Santos, Francisco; Ruiz-Nuño, Ana.
Affiliation
  • Wojnicz A; *Instituto-Fundación Teófilo Hernando, Universidad Autónoma de Madrid, Madrid, Spain;†Departamento de Farmacología y Terapéutica, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain;‡Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain;§Servicio de Inmunología, Instituto de Investigación Sanitaria, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, S
Ther Drug Monit ; 39(3): 252-262, 2017 06.
Article in En | MEDLINE | ID: mdl-28490048
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Protein Kinase Inhibitors / Imatinib Mesylate / Dasatinib Type of study: Guideline Limits: Humans Language: En Journal: Ther Drug Monit Year: 2017 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Protein Kinase Inhibitors / Imatinib Mesylate / Dasatinib Type of study: Guideline Limits: Humans Language: En Journal: Ther Drug Monit Year: 2017 Document type: Article